Completes Oversubscribed Placement
Completes Oversubscribed Placement
Melbourne, Sep 14, 2018 AEST (ABN Newswire) - Bluechiip Limited (ASX:BCT), is pleased to confirm that, further to the ASX Release dated 10 September 2018, the Company has completed the share placement (Placement) of ordinary shares that has raised $5.5 million of funding.

The Company has allotted 93,220,339.00 fully paid ordinary shares at $0.059 (5.9 cents) each to raise a total of $5.5million. After the allotment of the above securities, the Company has 490,253,716 fully paid ordinary shares on issue.

Attached is the Appendix 3B (see link below) in relation to the Placement.

To view the release, please visit:
http://abnnewswire.net/lnk/5PFJ5AEY


About Bluechiip Ltd

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) has developed a wireless tracking solution for the healthcare and life science, security, defence and manufacturing industries which represents a generational change from current methods such as labels (hand-written and pre-printed), barcodes (linear and 2D) and microelectronic integrated circuit (IC)-based RFID (Radio Frequency Identification).

The unique tag is based on MEMS technology and contains no electronics. The tag can either be embedded or manufactured into a storage product, such as vials or bags. Easy identification, along with any associated information from the tag such as temperature can be detected by a reader, which can also sense the temperature of the tagged items. The traditional identification technologies have significant limitations. Whereas a barcode requires a visible tag or line-of-sight optical scan, bluechiip(R) technology does not. Unlike labels, barcodes and RFID, the bluechiip(R) technology can sense the temperature of each item a tag is attached to, or embedded in.

The bluechiip(R) technology has initial applications in the healthcare industry particularly those businesses which require cryogenic storage facilities (biobanks and biorepositories). bluechiip(R) offers the only technology that enables accurate and reliable tracking of products including stem cells, cord blood, and other biospecimens. In addition to functioning in extreme temperatures, the bluechiip(R) tracking solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

The bluechiip(R) technology has other healthcare applications in pathology, clinical trials and forensics. Several other key markets outside of healthcare include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Further information is available at http://www.bluechiip.com

    


Contact

Bluechiip Ltd
T: +61-3-9763-9763
E: info@bluechiip.com
WWW: www.bluechiip.com



Related Companies

Bluechiip Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 54) (Last 30 Days: 250) (Since Published: 945) 
ANALYTICS: LOGIN HERE

Bluechiip Ltd NEWS: RECENT VISITS (5298)

Research Report

Social Media